Amy Schacterle
Chief Regulatory Officer · Acumen Pharmaceuticals, Inc.
Individual
- 2024
- Jan 21, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Amy Schacterle files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Derek M. Meisner - $105K in ABOS purchases and sales in the last 12 months
- Derrell Porter - $75K in ABOS purchases and sales in the last 12 months
- Daniel Joseph Oconnell - $22K in ABOS purchases and sales in the last 12 months
- Nathan B. Fountain - $14K in ABOS purchases and sales in the last 12 months
- Matt Zuga - $8K in ABOS purchases and sales in the last 12 months
- Eric Siemers - $6K in ABOS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Amy Schacterle?
Amy Schacterle is a corporate insider, tracked as Chief Regulatory Officer of Acumen Pharmaceuticals, Inc. (ABOS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Amy Schacterle last file a Form 4?
The most recent primary Form 4 on record is dated 21 January 2026, one of 2 filings going back to 2024.
